Because my practice focuses on complex commercial disputes–especially cases involving antitrust, oil and gas, and patents–I keep daily track of important decisions by the U.S. Supreme Court and the 13 U.S. Courts of Appeals.
You can follow along during the week on Twitter (@contingencyblog) or here at The Contingency each Monday with this Commercial Case Roundup: U.S. Appeals.
Continue Reading Commercial Case Roundup: U.S. Appeals
Finding your patents
Since 1990, 4,008,329 utility patents have won U.S. Patent and Trademark Office approval. In 2014 alone, the USPTO granted more than 300,000 of them. And those awards went to a wide range of patenting entities — 38,000 of them, in fact.
If you do legal work for companies of any size, those clients of yours likely own at least one patent and may have quite a few (several hundred entities received 40 or more patent grants just in 2014). Do you have any idea how many or what inventions they cover?
Don’t worry if you don’t. You can get a list and see a copy of the patents in no time flat.
Continue Reading Should You Do a Patent Portfolio Review?
All nine justices on the U.S. Supreme Court today agreed to wipe out patents that told doctors how to tell how much of a drug to give a patient. The patents' sin? They did little more than describe a "law of nature".
Prometheus Labs held sole rights to a couple of patents. The patents dealt